Clinical and Experimental Hypertension
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.8 | Q1 | 89.9% | 0.934 | Q1 | 82.0% |
| 2024 | 3.5 | Q2 | 74.7% | 0.729 | Q2 | 74.9% |
| 2023 | 1.5 | Q3 | 26.4% | 0.448 | Q3 | 61.3% |
| 2022 | 12.3 | Q1 | 97.3% | 0.438 | Q3 | 62.1% |
| 2021 | 2.1 | Q4 | 38.0% | 0.481 | Q3 | 65.9% |
| 2020 | — | — | 0.555 | Q3 | 69.5% | |
| 2019 | — | — | 0.520 | Q2 | 68.7% | |
| 2018 | — | — | 0.520 | Q2 | 66.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1064-1963
ISSN
1525-6006
region
Northern America
coverage
1978-2026